Buy CJC-1295 No DAC + Ipamorelin Online
CJC-1295 No DAC + Ipamorelin combines a short-acting GHRH analogue with a selective growth-hormone secretagogue. It is one of the most commonly discussed peptide combinations for research into GH release, IGF-1, and body composition.
Product Information
CJC-1295 No DAC activates GHRH receptors, while ipamorelin acts through GHSR and is designed to stimulate GH release with greater selectivity than older secretagogues.
How Does It Work?
The two peptides stimulate GH release through separate but complementary receptor pathways, creating a combined GH-secretagogue effect.
Benefits
Growth-Hormone Research
CJC-1295 No DAC directly stimulates GHRH receptors, while ipamorelin stimulates the secretagogue pathway, making the combination useful for investigating GH release.
IGF-1 Research
The resulting GH signaling can increase IGF-1, a major mediator of growth-hormone activity in muscle, bone, and connective tissue.
Recovery Research
GH and IGF-1 participate in tissue repair and protein metabolism, which is why this combination is frequently investigated in experimental recovery models.
Body-Composition Research
GH signaling also influences fat metabolism and protein turnover, making the combination relevant to experimental body-composition studies.
Side Effects
Commonly reported effects include water retention, headache, fatigue, tingling, joint discomfort, appetite changes, and altered glucose levels.
Dosage
Current community protocols commonly use approximately 100–300 mcg CJC-1295 No DAC plus 100–300 mcg ipamorelin per administration, generally once or more daily depending on the protocol.
Research References
Dominikowski A, et al. The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis. Front Endocrinol. 2026.
PubMed — GH/IGF-1 Peptide Review
Purerawz Disclaimer
Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an independent information and affiliate platform. Where available, links may direct readers to independent third-party providers, and Purerawz may receive a commission from qualifying purchases at no additional cost to the reader.
The information provided is for educational and informational purposes only. Dosage figures may reflect published research protocols, historical clinical use, or reported community practices and should not be interpreted as personalized medical instructions. Research findings—particularly those from animal, cellular, or small early-stage studies—do not establish that a product is safe or effective for every individual or condition.
